Repeated Switching Between CT-P17 and EU Reference Adalimumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: A Randomized, Double-Blind, Active-Controlled, Phase 3, Interchangeability Study
Titel:
Repeated Switching Between CT-P17 and EU Reference Adalimumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: A Randomized, Double-Blind, Active-Controlled, Phase 3, Interchangeability Study
Auteur:
Lebwohl, Mark G. Koo, John Y. Jaworski, Janusz Trefler, Jakub Daniluk, Stefan Dudek, Anna Baran, Wojciech Owczarek, Witold Kolinek, Joanna Brzewski, Paweł Sikora, Mariusz Krogulec, Marek Kim, SungHyun Bae, YunJu Jeon, DaBee Choi, EunJin Cha, JungBin Lee, HyunJin Choi, SuJin Pariser, David M.